Today was a whirlwind of updates on one of my patients. I only have one real job for inpatient shifts: write the daily progress note. Typically, all the information needed for the note is discussed in morning rounds. I can then spend an hour or so in the afternoon going through the computer to write a draft of a note that my supervising resident can edit and co-sign.
But today, my patient's condition (and even diagnosis) changed about every hour. Accordingly, his note changed several times too. Thankfully, by the time I needed to leave, my resident was willing to help write in the most current plan (of which I hadn't even heard by that point).
TIL: Growth hormone treatment is associated with rare cases of sudden death in children with Prader-Willi syndrome. Prader-Willi is a rare genetic disease caused by the loss of part of chromosome 15 that results in many developmental symptoms, including short stature. A logical treatment is growth hormone, to boost these patients' heights. But in very rare cases, patients treated with growth hormone have sudden unexplained deaths. So why don't we just not treat any of these patient's with growth hormone? Rarely, people die from one treatment for a rare disease. There is so little data on this connection, that we can't really be sure that they are linked.
No comments:
Post a Comment